Play the video to hear the HeartChain founders describe how crowdfunding, blockchains and smart contracts will create the future of funding for medical technology companies. The HeartChain platform will offer everyone the opportunity to participate in financing and benefiting in life-changing innovations.
Priority access to a pipeline of exclusive, fully-vetted life sciences product development opportunities
Interest in multiple product development projects - concurrently or consecutively
Participation in the fastest growing sectors of medical innovation
Assist in development of innovative medical products you may then use, donate to someone in need, or offer back to innovators at retail price
A non-dilutive, off balance sheet, non-security related alternative to traditional VC investment and government grants
A secure platform where your innovation can be seen by screened prospective investors
Bridging the gap between funding and commercialization with an efficient, transparent and discernible process that brings breakthroughs to life faster
The HeartChain network of experts will provide guidance and resources, so you can focus on what you do best – innovative discoveries
Download the comprehensive whitepaper to learn how HeartChain will support medical innovation and produce a win-win situation for med-tech companies, their sponsors and the general community.
Version 1.2.1, May 2018DOWNLOAD
The medical and scientific research industries have very high rates of early-stage failure. This is due to a lack of access to capital, where VC structure is stacked against the science innovators' interest and where equity dilution discourages early stages sponsors. But this is all about to change.
HeartChain will utilize blockchains and smart contracts, to makes sponsoring the development of medical innovation products accessible, transparent and friction-free for both sponsors and innovators.
Sponsors buy HeartChain Tokens (HCT). This gives them membership to the HeartChain community. Membership gives sponsors the opportunity to support the development of particular product innovations, at the early-stage lower cost of manufacture, at a discounted rate. Each product innovation has its own funding program on the HeartChain platform. Sponsors can participate in any project of their choice.
Innovators are instantaneously connected at early-stage development, with a huge pool of sponsors from around the world, at extremely low cost. This eliminates equity dilution and enables innovators to focus on R&D rather than fundraising.
Join us, for good.
HeartChain friends and family private pre-TGE, April 2018
Formation of HeartChain advisory group
HeartChain public pre-TGE
– June 30
Full advisory group of clinical and scientific experts in place
Signing up IC commerce
Full operating platform in place to launch portfolio TGE
HeartChain full TGE – July 31
First IPT# TGE launched
Second IPT# TGE launched
Chief Scientific and Clinical Officer
Chief Technical Officer
Healthcare and Tokenization
Crowdfunding, Blockchain and Finance
Legal Counsel and Regulations
Events and Business Development
Social Media Marketing & Research
Medium - June 13, 2018read more
Medium - June 5, 2018read more